Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2022

Feb 8, 2022

31873_dirs_2022-02-08_744e2695-e945-4585-a17e-b0a95482aea1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2022-02-04

Reporting Person: JOHANNESSEN JAN (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-04 Common Stock S 253 $58.879 Disposed 1645 Direct

Footnotes

F1: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously
granted to the Reporting Person.